Mantle cell lymphoma trials in Argentina

1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  Where

  CABA, Ciudad Autonoma Buenos Aires, Córdoba

  Age

  18 years and over

  People

  300 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06742996 · EU 2024-515593-27-00